DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Crisaborole
Crisaborole
4 Tier)
Changes to the Highmark Drug Formularies
Pharmacy and Poisons Act 1979
Phosphodiesterase Inhibitors: Could They Be Beneficial for the Treatment of COVID-19?
PFIZER INC. (Exact Name of Registrant As Specified in Its Charter)
Patent Application Publication ( 10 ) Pub . No . : US 2019 / 0192440 A1
Health Choice Arizona Medication Prior Authorization Criteria October
2021 Formulary List of Covered Prescription Drugs
Metabolic Enzyme/Protease
April 1, 2019
Eparations, PDE-4 Enzyme Catalytic Domains, and Full-Length Enzymes Prepared by Recombinant Means Were Characterized
2020 Aetna Standard Plan
Buffalo Medical Group, P.C. Robert E
Australian Public Assessment Report for Crisaborole
49Th Annual ESDR Meeting September 18–21, 2019 Bordeaux, France
Sharp Health Plan 2020 Formulary List of Covered Prescription Drugs
207695Orig1s000
Treatment of Skin Inflammation with Benzoxaborole Phosphodiesterase
Top View
IEHP Medi-Cal Prior Authorization Criteria September 2020
Medicaid List of Covered Drugs (Formulary)
FEP 5 Tier Rx Drug Formulary (607) Standard Option
Drug Formulary
Treatment of Skin Inflammation with Benzoxaborole PDE Inhibitors
WO 2016/161086 Al 6 October 2016 (06.10.2016) P O P C T
Bioactive Compound Library Plus (96-Well)
207695Orig1s000
Granuloma Annulare: a Brief Review and Up-To-Date Information on Treatment Options
Clinical Review Melinda L Mccord NDA 207695 EUCRISA (Crisaborole) Ointment, 2%
ATC Vet 2021 Atccode Atcdescription Atcdescriptionsi QA ALIMENTARY TRACT and METABOLISM ZDRAVILA ZA BOLEZNI PREBAVIL in PRESNOVE
FEP 5 Tier Managed Rx Drug Formulary (807) Basic Option
PLUS Drug Formulary (DMHC)
Paragraph IV Patent Certifications (PPIV)
Rxoutlook® 1St Quarter 2021
Drug Repurposing Compound Library (96-Well)
AUM Drug List
Issue and Citation Type: M= Main Feature; L= Literature Review; F= FDA Update; C= Correction)
Immediate Open Access
INN-Nimet 1 20.8.2019 a Abacavir Abacavirum Abakaviiri
Publication Agenda CHMP 09-12 December 2019 CHMP